In 2021, 2 268 confirmed cases of listeriosis were reported by 30 EU/EEA Member States. The EU/EEA notification rate was 0.51 per 100 000 population. Germany, France, and Italy had the highest numbers of reported cases (560, 435 and 241, respectively), corresponding to 54.5% of all cases reported in the EU/EEA. The highest incidence rates were observed in Iceland, Finland, and Denmark. Figure 1 illustrates the country-specific age-standardised rates per 100 000 population.
For 2021, 6 534 confirmed cases of STEC infection were reported by 30 EU/EEA countries (Table 1). Twenty-seven countries reported at least two confirmed cases, and three countries reported no cases. The EU/EEA notification rate was 2.2 cases per 100 000 population, representing a 37.5% increase compared with the previous year.
Hepatitis A cases in 2021 were at their lowest levels since EU-level hepatitis A surveillance began in 2007, while five other food and waterborne diseases are rising towards pre-pandemic levels. The information is revealed in the Annual Epidemiological Report 2021, of which six chapters are published today by ECDC.
This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring and surveillance activities carried out in 2021 in 27 MSs, the United Kingdom (Northern Ireland) and nine non-MSs.
This report presents the results of the eighth round of the external quality assessment (EQA-8) scheme for Listeria monocytogenes (L. monocytogenes) typing, organised for national public health reference laboratories (NPHRLs) providing data to the Food- and Waterborne Diseases and Zoonoses Network (FWD-Net), managed by ECDC.
Antibiotic resistance in Salmonella and Campylobacter bacteria is still high, says a report released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.